hotspot -WSS

hotspot

author：focus 2025-09-30 00:48:28 - browse：2

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Was Amgen transparent enough on FDA's concern on cancer drug?

WSS

Nonprofit, backed by Microsoft, to certify AI tools in health care

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Physician executives need more than on

Liquid biopsy for lung cancer is launched by Delfi

Arena BioWorks launches in Cambridge to speed drug discovery

Male doctors called my cancer incurable. A female doctor showed it wasn't

hotspot

hotspot

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Male doctors called my cancer incurable. A female doctor showed it wasn't

New air purifier tech could be key to improving indoor air quality

FDA authorizes Novavax’s updated Covid

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

As demand for Covid shots wanes, Moderna seeks its next success

FDA authorizes Novavax’s updated Covid

hotspot

Study suggests new cause of Down syndrome: cells linked to aging

Physician executives need more than on

Chemotherapy drug shortage eases slightly but still widespread

Why Charlie Gard's case is so disturbing to Americans

JPM pitch from hospitals? Revenue streams outside of patient care

Chan Zuckerberg Biohub Chicago to focus on inflammation

explore

knowledge

leisure time

knowledge